Ellevest, Inc. Kiniksa Pharmaceuticals, Ltd. Transaction History

Ellevest, Inc.

  • $1.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022
BUY
$9.76 - $13.41 $3,562 - $4,894
365 New
365 $5,000
Q3 2020

Oct 26, 2020
SELL
$15.21 - $25.53 $91 - $153
-6 Closed
0 $0
Q2 2020

Jul 06, 2020
SELL
$15.08 - $26.0 $256 - $442
-17 Reduced 73.91%
6 $0
Q1 2020

Apr 13, 2020
BUY
$11.0 - $19.76 $55 - $98
5 Added 27.78%
23 $0
Q4 2019

Feb 05, 2020
BUY
$5.24 - $12.96 $94 - $233
18 New
18 $0

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $687M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Ellevest, Inc. Portfolio

Follow Ellevest, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email